|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Primary Dysmenorrhea | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Dysmenorrhea | |||||
| 3 | More general conditions related to this trial | ||||
| Menstruation Disturbances | |||||
| Pain | |||||
| Pathologic Processes | |||||
| Pelvic Pain | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| YAZ flex (SH T00186D) | |||||
| YAZ (SH T00186D) | |||||
| 5 | Sponsors listed in this trial | ||||
| Bayer | |||||